Drug Safety & Medicine Alerts
MHRA revises semaglutide product information for rare risk of eye disease
Semaglutide helps patients with type 2 diabetes. It is also prescribed for weight management and cardiovascular risk reduction among obese patients
Feb 07, 2026







